Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Total assets
Total assets on the balance sheet as of September 2023 : $7.42 M
According to Athersys's latest financial reports the company's total assets are $7.42 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Athersys - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $27.73 M | -53.92% |
| 2021-12-31 | $60.18 M | 0.79% |
| 2020-12-31 | $59.71 M | 43.32% |
| 2019-12-31 | $41.66 M | -32.5% |
| 2018-12-31 | $61.73 M | 83.76% |
| 2017-12-31 | $33.59 M | 76.25% |
| 2016-12-31 | $19.06 M | -24.15% |
| 2015-12-31 | $25.12 M | -12.5% |
| 2014-12-31 | $28.71 M | -16% |
| 2013-12-31 | $34.18 M | 23.86% |
| 2012-12-31 | $27.6 M | 75.8% |
| 2011-12-31 | $15.7 M | -17.82% |
| 2010-12-31 | $19.1 M | -32.56% |
| 2009-12-31 | $28.33 M | -16.37% |
| 2008-12-31 | $33.87 M | -35.13% |
| 2007-12-31 | $52.22 M | |
| 2006-12-31 | $N/A | -100% |
| 2005-12-31 | $0 M | 0% |
| 2004-12-31 | $0 M | -100% |
| 2003-12-31 | $30.5 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 2,255,661.98% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 3,049,186.48% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 1,307,842.92% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 1,882,183.25% | 🇫🇷 France |
 Merck MRK | $106.67 B | 1,436,020.09% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | 1,280,985.08% | 🇺🇸 USA |
 Moderna
MRNA | $18.42 B | 247,961.39% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |